We found significantly higher levels of Ier5 mRNA expression in all ovarian cancer cells (MOV, ID8G, and HM-1 cells) compared to normal ovarian cells (p53 MOSE and T-Ag-MOSE cells) (Figure 2B). This evidence concerns the gene TP53 and ovarian carcinoma.